BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Accenture
McKinsey
McKesson
Fuji
Farmers Insurance
Cipla
Medtronic
Novartis

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,629,021

« Back to Dashboard

Summary for Patent: 5,629,021
Title: Micellar nanoparticles
Abstract:The present invention relates to micellar nanoparticles and methods of their production. Micellar nanoparticles are made by hydrating a mixture of an oil, a stabilizer/surfactant, and an alcoholic initiator with an aqueous solution. These micellar nanoparticles are normally less than 100 nanometers in diameter. The micellar nanoparticles are particularly advantageous in delivering materials such as estradiol topically through the skin because their small size allows easy penetration.
Inventor(s): Wright; D. Craig (Gaithersburg, MD)
Assignee: Novavax, Inc. (Rockville, MD)
Application Number:08/380,942
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 5,629,021

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,629,021

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4970996 ➤ Subscribe
Australia 711744 ➤ Subscribe
Brazil 9606996 ➤ Subscribe
Canada 2211262 ➤ Subscribe
China 1144583 ➤ Subscribe
China 1179698 ➤ Subscribe
Germany 69627309 ➤ Subscribe
Denmark 0806894 ➤ Subscribe
European Patent Office 0806894 ➤ Subscribe
Spain 2200055 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Department of Justice
Cipla
US Army
Novartis
Harvard Business School
Express Scripts
Argus Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot